General Information of Drug Formulation (ID: F24243)

Formulation Name
Etoposide Phosphate eq 100mg base/vial injectable
Company
E.R. Squibb & Sons L.L.C.; H2-Pharma
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Dextran E00466 4125253 Lyophilization aid
Sodium citrate anhydrous E00102 6224 Alkalizing agent; Buffering agent; Complexing agent; Emulsifying agent